We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$17.5B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
-10.7%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$11.7B
AUM Growth
-$3.17B
(-21%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-9.88%
Top 10 Holdings %
Top 10 Hldgs %
46.25%
Holding
136
New
17
Increased
36
Reduced
23
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$440M |
| 2 |
IQVIA
IQV
|
+$269M |
| 3 |
AGN
Allergan plc
AGN
|
+$247M |
| 4 |
General Dynamics
GD
|
+$183M |
| 5 |
Fidelity National Information Services
FIS
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$793M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$282M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$236M |
| 4 |
S&P Global
SPGI
|
+$175M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.69% |
| 2 | Communication Services | 12.39% |
| 3 | Technology | 10.92% |
| 4 | Industrials | 5.44% |
| 5 | Financials | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $1.65B | 14.14% |
9,300,000
+1,310,000
| +16% | +$247M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $722M | 6.19% |
2,616,500
-1,768,500
| -40% | -$539M |
|
|
3
Fidelity National Information Services
FIS
$21.5B
| $562M | 4.83% |
4,621,208
+1,135,451
| +33% | +$158M |
|
|
4
Centene
CNC
$31.3B
| $431M | 3.7% |
+7,250,000
| New | +$440M |
|
|
5
IQVIA
IQV
$34.7B
| $403M | 3.46% |
3,739,696
+1,885,009
| +102% | +$269M |
|
6
Thermo Fisher Scientific
TMO
$211B
| $353M | 3.03% |
1,243,215
+390,055
| +46% | +$123M |
|
7
Alphabet (Google) Class C
GOOG
$3.9T
| $343M | 2.95% |
5,903,460
+405,400
| +7% | +$27.5M |
|
8
Charter Communications
CHTR
$14.7B
| $316M | 2.71% |
723,328
+40,235
| +6% | +$19.7M |
|
|
PPLI
9
People Inc
PPLI
$3.1B
| $307M | 2.64% |
9,596,124
-1,966,786
| -17% | -$77.9M |
|
10
AbbVie
ABBV
$458B
| $305M | 2.62% |
4,000,000
+1,500,000
| +60% | +$128M |
|
11
Wabtec
WAB
$51.1B
| $304M | 2.61% |
6,322,354
+1,253,167
| +25% | +$86M |
|
|
INFO
12
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $296M | 2.54% |
4,925,538
+2,181,988
| +80% | +$157M |
|
13
Microsoft
MSFT
$2.84T
| $288M | 2.47% |
1,823,720
-362,070
| -17% | -$59.5M |
|
14
Visa
V
$677B
| $284M | 2.44% |
1,763,268
+240,808
| +16% | +$45.4M |
|
15
Elevance Health
ELV
$81.9B
| $284M | 2.44% |
1,250,000
| – | – |
|
|
16
General Dynamics
GD
$105B
| $276M | 2.37% |
2,083,681
+1,102,316
| +112% | +$183M |
|
17
Sherwin-Williams
SHW
$78.3B
| $234M | 2.01% |
1,527,390
+424,065
| +38% | +$76.5M |
|
18
Salesforce
CRM
$134B
| $232M | 2% |
1,614,488
-110,392
| -6% | -$18.9M |
|
19
Cigna
CI
$76.6B
| $221M | 1.9% |
1,250,000
-250,000
| -17% | -$48.5M |
|
20
Alibaba
BABA
$269B
| $218M | 1.88% |
1,123,500
-9,000
| -0.8% | -$1.88M |
|
|
XLRN
21
DELISTED
Acceleron Pharma
XLRN
| $195M | 1.68% |
2,175,000
+175,000
| +9% | +$13.6M |
|
22
Meta Platforms (Facebook)
META
$1.51T
| $181M | 1.56% |
1,087,524
+57,211
| +6% | +$11.2M |
|
23
Equinix
EQIX
$107B
| $176M | 1.51% |
281,933
-134,390
| -32% | -$80.4M |
|
24
Exelixis
EXEL
$13.9B
| $172M | 1.48% |
10,000,000
+2,500,000
| +33% | +$45.7M |
|
25
Iovance Biotherapeutics
IOVA
$2.23B
| $172M | 1.48% |
5,750,000
-500,000
| -8% | -$13.3M |
|
Similar funds
BBA
MCM
LA
CM
ASRS
PP
VMPIC
HNB
Farallon Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Farallon Capital Management held 136 positions worth $11.7B, down 21% from $14.8B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Farallon Capital Management withdrew a net $1.15B in Q1 2020, closing 34 positions and reducing 23 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $793M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 38% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Farallon Capital Management opened a new position in Centene worth $431M.
- Farallon Capital Management's largest Q1 2020 buy was Centene: 7,250,000 shares worth $431M.
- Farallon Capital Management added most to IQVIA in Q1 2020, an estimated $269M increase.
- Farallon Capital Management's biggest Q1 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $104M.
- Farallon Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $793M.
- Farallon Capital Management's ten largest holdings make up 46% of its $11.7B portfolio in Q1 2020.
- Farallon Capital Management opened 17 new positions and closed 34 in Q1 2020.
- Farallon Capital Management's portfolio value fell 21% quarter-over-quarter to $11.7B.
Based on Farallon Capital Management's 13F filing for Q1 2020, filed 15 May 2020.